DHT Inhibits the Aβ25–35-Induced Apoptosis by Regulation of Seladin-1, Survivin, XIAP, bax, and bcl-xl Expression Through a Rapid PI3-K/Akt Signaling in C6 Glial Cell Lines

Neurochemical Research

Volumn 40, Issue 1, 2015, Pages 41-48

  Bing, Lelin ^a   Wu, Junfeng ^a   Zhang, Jianfeng ^a   Chen, Yinghui ^a   Hong, Zhen ^b   Zu, Hengbing ^a  

^a JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Dihydrotestosterone; Glia; IAPs; Seladin 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMYLOID BETA PROTEIN[25-35]; ANDROSTANOLONE; LIPOCORTIN 5; NAPROXEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL XL; PROTEIN KINASE B; SELADIN 1; SURVIVIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); ANDROGEN RECEPTOR; BAX PROTEIN, RAT; BCL2L1 PROTEIN, RAT; BIRC5 PROTEIN, RAT; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; OXIDOREDUCTASE; PEPTIDE FRAGMENT; PROTEIN BCL X; SELADIN-1 PROTEIN, RAT; XIAP PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; GLIA CELL; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GLIA; METABOLISM;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL LINE; DIHYDROTESTOSTERONE; INHIBITOR OF APOPTOSIS PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROGLIA; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84922004960     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1463-3     Document Type: Article

References (37)

1. Rosario ER, Chang L, Stanczyk FZ, Pike CJ (2004) Age-related testosterone depletion and the development of Alzheimer disease. JAMA 292(12):1431–1432
2. Carroll JC, Rosario ER (2012) The potential use of hormone-based therapeutics for the treatment of Alzheimer’s disease. Curr Alzheimer Res 9(1):18–34
3. Seyedreza P, Alireza MN, Seyedebrahim H (2012) Role of testosterone in memory impairment of Alzheimer disease induced by Streptozotocin in male rats. Daru 20(1):98
4. Pike CJ, Carroll JC, Rosario ER, Barron AM (2009) Protective actions of sex steroid hormones in Alzheimer’s disease. Front Neuroendocrinol 30(2):239–258
5. Pike CJ, Nguyen T-Vi V, Ramsden M, Yao M, Murphy MP, Rosario ER (2008) Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav 53(5):693–705
6. Kalaria RN (1999) Microglia and Alzheimer’s disease. Curr Opin Hematol 6(1):15–24
7. Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, Chan S, Li C, Rowitch DH, Wong WH, DePinho RA (2004) Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci USA 101(22):8384–8389
8. Gatson JW, Singh M (2007) Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148(5):2458–2464
9. Foradori CD, Weiser MJ, Handa RJ (2008) Non-genomic actions of androgens. Front Neuroendocrinol 29(2):169–181
10. Yamagishi S, Yamada M, Koshimizu H, Takai S, Hatanaka H, Takeda K, Ichijo H, Shimoke K, Ikeuchi T (2003) Apoptosis-signal regulating kinase-1 is involved in the low potassium-induced activation of p38 mitogen-activated protein kinase and c-Jun in cultured cerebellar granule neurons. J Biochem 133(6):719–724
11. Gatson JW, Kaur P, Singh M (2006) Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147(4):2028–2034
12. Xia Y, Cheng Z, Wang JL, Noelle C, Anastasio K, Johnson M (2010) Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology 58(2):330
13. Nguyen N, Lee SB, Lee YS, Lee KH, Ahn JY (2009) Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 34(5):942–951
14. Kudo W, Lee HP, Smith MA, Zhu X, Matsuyama S, Lee HG (2012) Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity. Cell Death Dis 3(5):e309
15. Semaan SJ, Murray EK, Poling MC, Dhamija S, Forger NG, Kauffman AS (2010) BAX-dependent and BAX-independent regulation of Kiss1 neuron development in mice. Endocrinology 151(12):5807–5817
16. Shang YC, Chong ZZ, Wang S, Maiese K (2012) Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL. Aging (Albany NY) 4(3):187–201
17. Pfister B, Oyler G, Betenbaugh M, Bao G (2004) The effects of BclXL and Bax over-expression on stretch-injury induced neural cell death. Mech Chem Biosyst 1(4):233–243
18. Van DMF, Huang DC (2006) How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16(2):203–213
19. Scorrano L, Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304(3):437–444
20. Degli EM, Dive C (2003) Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 304(3):455–461
21. Kang MH, Reynolds CP (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15(4):1126–1132
22. Chong ZZ, Li F, Maiese K (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer’s disease. Brain Res Rev 49(1):1–21
23. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer’s disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345–7352
24. Alessandro P, Mario S (2008) Neuroprotective effects of the Alzheimer’s disease-related gene seladin-1. J Mol Endocrinol 41:251–261
25. Peri A, Serio M (2008) Estrogen receptor-mediated neuroprotection: the role of the Alzheimer’s disease-related gene seladin-1. Neuropsychiat Dis Treat 4(4):817–824
26. Zu H, Wu J, Zhang J, Yu M, Hong Z (2012) Testosterone up-regulates seladin-1 expression by iAR and PI3-K/Akt signaling pathway in C6 cells. Neurosci Lett 514(1):122–126
27. Altieri DC (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem J 430(2):199–205
28. Maier JK, Lahoua Z, Gendron NH, Fetni R, Johnston A, Davoodi J, Rasper D, Roy S, Slack RS, Nicholson DW, MacKenzie AE (2002) The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 22(6):2035–2043
29. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB (2000) Neuroprotection by the inhibition of apoptosis. Brain Pathol 10(2):283–292
30. Batrinos ML (2012) Testosterone and aggressive behavior in man. Int J Endocrinol Metab 10(3):563–568
31. Filová B, Ostatníková D, Celec P, Hodosy J (2013) The effect of testosterone on the formation of brain structures. Cells Tissues Organs 197(3):169–177
32. Białek M, Zaremba P, Borowicz KK, Czuczwar SJ (2004) Neuroprotective role of testosterone in the nervous system. Pol J Pharmacol 56(5):509–518
33. Gold SM, Voskuhl RR (2006) Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders. Curr Opin Investig Drugs 7(7):625–630
34. Spence RD, Voskuhl RR (2012) Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 33(1):105–115
35. Gold SM, Voskuhl RR (2009) Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 175:239–251
36. Dienel GA (2012) Exploring and mapping the world of astrocytes. Neurochem Res 37(11):2295–2298
37. Rossi D, Volterra A (2009) Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull 80(4–5):224–232